Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Breakthrough Pain After Brachial Plexus Block in People With Type 2 Diabetes

Official title: An Observational Study on Incidence and Clinical Characteristics of Breakthrough Pain Following Brachial Plexus Block in Adult Patients With Diabetes Mellitus

Run by Second Hospital of Shanxi Medical University · NCT07833930 · Data updated 2026-11-12

This study tests how often rebound pain happens after a nerve block in adults with type 2 diabetes compared with those without diabetes.

More Postoperative Pain trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment216 (estimated)
SponsorSecond Hospital of Shanxi Medical University
Academic / other
Locations1 site (Taiyuan)
StatusRecruiting
StartedSeptember 20, 2025
Main results expectedSeptember 20, 2026
Study endsSeptember 20, 2026
Registry record updatedSeptember 22, 2026
Trial IDNCT07833930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing elective upper-extremity surgery planned for ultrasound-guided brachial plexus block with 0.375% ropivacaine.

Probably not a fit

Patients without diabetes or those not experiencing rebound pain may see limited direct benefits; results may not apply to other anesthetic techniques.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults undergoing elective upper-extremity surgery with ultrasound-guided brachial plexus block using ropivacaine to compare postoperative rebound pain between people with type 2 diabetes and non-diabetic controls. Baseline data such as HbA1c and sensory thresholds are collected, and post-block pain scores, block duration, analgesic use, and recovery are recorded for up to 48 hours. The aim is to quantify incidence and characterize the clinical features of rebound-breakthrough pain and its relationship with diabetes status. No experimental interventions are introduced beyond standard anesthesia care. Findings may inform perioperative pain management strategies for diabetic patients receiving nerve blocks.

Why it matters

Potential benefit: If successful, the study could help tailor pain management for diabetic patients to reduce rebound pain and opioid use after brachial plexus block.

How similar studies have gone: Previous work has explored rebound pain after nerve blocks, but data specific to type 2 diabetes and brachial plexus block remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or older
* Undergoing elective upper-extremity surgery
* Planned for ultrasound-guided brachial plexus block with 0.375% ropivacaine
* Able to cooperate with pain assessment and follow-up within 48 hours after block
* Written informed consent obtained

Exclusion Criteria:

* Allergy or contraindication to amide-type local anesthetics
* Pre-existing peripheral neuropathy of the affected upper limb
* Chronic regular use of opioids before surgery
* Coagulopathy or infection at the block puncture site
* Cognitive dysfunction unable to complete NRS pain evaluation
* Pregnancy or lactation
* Incomplete clinical data expected during follow-up

Where it's running

  • Second Hospital of Shanxi Medical University
    Taiyuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.